• Encompass Health lifted 2026 guidance as of Aug. 5, 2026, projecting net operating revenue of $6.41 billion to $6.49 billion.
• Adjusted EBITDA outlook increased to $1.37 billion to $1.4 billion.
• Adjusted EPS forecast raised to $6.02 to $6.25.
• Guidance assumes 2026 adjusted free cash flow of $760 million to $865 million.
• Second-quarter results showed net operating revenue of $1.6 billion, adjusted EBITDA of $348 million, adjusted EPS of $1.55.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Encompass Health Corporation published the original content used to generate this news brief on August 05, 2026, and is solely responsible for the information contained therein.